NASDAQ:PDCO - Patterson Companies Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$24.42 -0.20 (-0.81 %)
(As of 06/25/2018 12:01 PM ET)
Previous Close$24.48
Today's Range$24.40 - $25.27
52-Week Range$20.57 - $48.29
Volume120,418 shs
Average Volume1.95 million shs
Market Capitalization$2.33 billion
P/E Ratio14.65
Dividend Yield4.22%
Beta1.12
Patterson Companies logoPatterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through Dental and Animal Health segments. The company's Dental segment offers consumable products, such as infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; patient education systems; and office forms and stationery. This segment also develops and sells technology solutions, such as practice management software and e-commerce solutions. In addition, it offers a range of related services, including software and design, maintenance and repair, and equipment financing services. The company's Animal Health segment distributes animal health products, such as pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritionals, consumable supplies, equipment, and software to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. This segment also offers a range of value-added services to animal health customers. Patterson Companies, Inc. serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in St. Paul, Minnesota.

Receive PDCO News and Ratings via Email

Sign-up to receive the latest news and ratings for PDCO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical & hospital equipment
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNASDAQ:PDCO
CUSIP70339510
Phone651-686-1600

Debt

Debt-to-Equity Ratio0.63
Current Ratio1.95
Quick Ratio1.00

Price-To-Earnings

Trailing P/E Ratio14.65
Forward P/E Ratio14.03
P/E Growth2.3

Sales & Book Value

Annual Sales$5.47 billion
Price / Sales0.42
Cash Flow$2.5227 per share
Price / Cash9.68
Book Value$15.45 per share
Price / Book1.58

Profitability

EPS (Most Recent Fiscal Year)$1.68
Net Income$170.89 million
Net Margins3.68%
Return on Equity11.05%
Return on Assets4.43%

Miscellaneous

Employees7,500
Outstanding Shares94,630,000

The Truth About Cryptocurrencies

Patterson Companies (NASDAQ:PDCO) Frequently Asked Questions

What is Patterson Companies' stock symbol?

Patterson Companies trades on the NASDAQ under the ticker symbol "PDCO."

How often does Patterson Companies pay dividends? What is the dividend yield for Patterson Companies?

Patterson Companies announced a quarterly dividend on Tuesday, June 12th. Investors of record on Friday, July 13th will be paid a dividend of $0.26 per share on Friday, July 27th. This represents a $1.04 dividend on an annualized basis and a yield of 4.23%. The ex-dividend date is Thursday, July 12th. View Patterson Companies' Dividend History.

How will Patterson Companies' stock buyback program work?

Patterson Companies announced that its Board of Directors has approved a share repurchase program on Wednesday, March 14th 2018, which authorizes the company to buyback $500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company's board believes its stock is undervalued.

How were Patterson Companies' earnings last quarter?

Patterson Companies, Inc. (NASDAQ:PDCO) issued its quarterly earnings results on Thursday, June, 21st. The company reported $0.30 EPS for the quarter, meeting the Zacks' consensus estimate of $0.30. The company had revenue of $1.40 billion for the quarter, compared to analysts' expectations of $1.43 billion. Patterson Companies had a net margin of 3.68% and a return on equity of 11.05%. The company's revenue was down 3.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.69 EPS. View Patterson Companies' Earnings History.

When is Patterson Companies' next earnings date?

Patterson Companies is scheduled to release their next quarterly earnings announcement on Wednesday, August, 22nd 2018. View Earnings Estimates for Patterson Companies.

What guidance has Patterson Companies issued on next quarter's earnings?

Patterson Companies updated its FY19 earnings guidance on Thursday, June, 21st. The company provided earnings per share guidance of $1.73-1.83 for the period, compared to the Thomson Reuters consensus estimate of $1.76.

What price target have analysts set for PDCO?

16 analysts have issued 12-month price targets for Patterson Companies' stock. Their forecasts range from $18.50 to $50.00. On average, they expect Patterson Companies' stock price to reach $31.1667 in the next twelve months. View Analyst Ratings for Patterson Companies.

What are Wall Street analysts saying about Patterson Companies stock?

Here are some recent quotes from research analysts about Patterson Companies stock:
  • 1. According to Zacks Investment Research, "Patterson has underperformed its industry in a year's time. Lackluster sales and earnings performance dampened Patterson Companies’ fourth-quarter results. However, the company’s strong fiscal 2019 guidance buoys optimism. We are upbeat about the Animal Health segment that has been performing well lately. The company provides a wide range of consumable supplies, equipment, software and value-added services. A broad spectrum of products cushions the company against economic downturns in the MedTech space. We believe that a diversified product portfolio, strong veterinary business prospects, accretive acquisitions and strategic partnerships are key growth catalysts. On the flip side, operating margins have been dull. Declining revenues in the dental segment is another headwind. The recent fall in the segment is driven by lower sales of CEREC and digital technology products." (6/25/2018)
  • 2. UBS Group AG analysts commented, "tough to fill" even with new product introductions — a view that is shared among others on the Street.The loss of Sirona could also generate further market share losses in consumables sales, which are expected to remain in the low-single digit range, Cherny continued. As such, it is not clear at this point in time if the company will be able to accelerate recent EBIT growth, especially when factoring in expectations for further EBIT margin pressures from the Animal Health mix shift.Meanwhile, Patterson hasn't yet brought in a permanent CEO, and once an executive is appointed, they will need to immediately implement a sales force rebuild, the analyst added. Also, the ongoing ERP investment (Enterprise Resource Planning) and roll-out continues to be an overhang and needs to be managed properly to fully take advantage of any new opportunity.While these issues are indeed fixable and the hiring of a new CEO could "pivot the company in a more sustainable direction," (7/11/2017)

Are investors shorting Patterson Companies?

Patterson Companies saw a increase in short interest during the month of May. As of May 15th, there was short interest totalling 13,376,031 shares, an increase of 35.9% from the April 30th total of 9,844,124 shares. Based on an average daily volume of 1,632,068 shares, the short-interest ratio is currently 8.2 days. Approximately 16.2% of the shares of the company are sold short. View Patterson Companies' Current Options Chain.

Who are some of Patterson Companies' key competitors?

Who are Patterson Companies' key executives?

Patterson Companies' management team includes the folowing people:
  • Mr. Les B. Korsh, VP, Gen. Counsel & Sec. (Age 48)
  • Ms. Ann B. Gugino, Special Advisor (Age 46)
  • Mr. Paul A. Guggenheim, Pres of Patterson Dental - Western Region (Age 58)
  • Mr. Scott P. Anderson, Non-Officer Special Advisor (Age 51)
  • Mr. Mark S. Walchirk, CEO, Pres & Director (Age 52)

Has Patterson Companies been receiving favorable news coverage?

Media coverage about PDCO stock has been trending somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Patterson Companies earned a media sentiment score of 0.16 on Accern's scale. They also gave media stories about the company an impact score of 45.82 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are Patterson Companies' major shareholders?

Patterson Companies' stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.25%), Barrow Hanley Mewhinney & Strauss LLC (2.21%), Thompson Siegel & Walmsley LLC (2.04%), Gamco Investors INC. ET AL (1.81%), Dimensional Fund Advisors LP (1.78%) and Wells Fargo & Company MN (1.43%). Company insiders that own Patterson Companies stock include Ann B Gugino, Ellen A Rudnick, James W Wiltz, John D Buck and Scott P Anderson. View Institutional Ownership Trends for Patterson Companies.

Which major investors are selling Patterson Companies stock?

PDCO stock was sold by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Guggenheim Capital LLC, Victory Capital Management Inc., The Manufacturers Life Insurance Company , W. E. Donoghue & Co. LLC, Van ECK Associates Corp, Highland Capital Management LP and Legal & General Group Plc. View Insider Buying and Selling for Patterson Companies.

Which major investors are buying Patterson Companies stock?

PDCO stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Thompson Siegel & Walmsley LLC, Cove Street Capital LLC, Rothschild Asset Management Inc., River Road Asset Management LLC, Gamco Investors INC. ET AL, Howard Capital Management Inc. and Seven Eight Capital LP. View Insider Buying and Selling for Patterson Companies.

How do I buy shares of Patterson Companies?

Shares of PDCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Patterson Companies' stock price today?

One share of PDCO stock can currently be purchased for approximately $24.56.

How big of a company is Patterson Companies?

Patterson Companies has a market capitalization of $2.33 billion and generates $5.47 billion in revenue each year. The company earns $170.89 million in net income (profit) each year or $1.68 on an earnings per share basis. Patterson Companies employs 7,500 workers across the globe.

How can I contact Patterson Companies?

Patterson Companies' mailing address is 1031 MENDOTA HEIGHTS RD, ST PAUL MN, 55120. The company can be reached via phone at 651-686-1600 or via email at [email protected]


MarketBeat Community Rating for Patterson Companies (PDCO)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  207 (Vote Outperform)
Underperform Votes:  387 (Vote Underperform)
Total Votes:  594
MarketBeat's community ratings are surveys of what our community members think about Patterson Companies and other stocks. Vote "Outperform" if you believe PDCO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PDCO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.